You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Microbial-Based Therapies in the Treatment of Inflammatory Bowel Disease – An Overview of Human Studies
|
|---|---|
| Published in |
Frontiers in Pharmacology, January 2019
|
| DOI | 10.3389/fphar.2018.01571 |
| Pubmed ID | |
| Authors |
Paulo José Basso, Niels Olsen Saraiva Câmara, Helioswilton Sales-Campos |
X Demographics
The data shown below were collected from the profiles of 28 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 4 | 14% |
| Mexico | 3 | 11% |
| United Kingdom | 2 | 7% |
| India | 1 | 4% |
| Ecuador | 1 | 4% |
| France | 1 | 4% |
| Switzerland | 1 | 4% |
| Peru | 1 | 4% |
| Austria | 1 | 4% |
| Other | 0 | 0% |
| Unknown | 13 | 46% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 18 | 64% |
| Scientists | 9 | 32% |
| Science communicators (journalists, bloggers, editors) | 1 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 160 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 160 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Unspecified | 28 | 18% |
| Researcher | 16 | 10% |
| Student > Master | 16 | 10% |
| Student > Bachelor | 14 | 9% |
| Student > Ph. D. Student | 12 | 8% |
| Other | 28 | 18% |
| Unknown | 46 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Unspecified | 28 | 18% |
| Medicine and Dentistry | 21 | 13% |
| Biochemistry, Genetics and Molecular Biology | 17 | 11% |
| Agricultural and Biological Sciences | 11 | 7% |
| Immunology and Microbiology | 8 | 5% |
| Other | 21 | 13% |
| Unknown | 54 | 34% |
Attention Score in Context
This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 September 2019.
All research outputs
#2,568,774
of 24,340,143 outputs
Outputs from Frontiers in Pharmacology
#1,046
of 18,285 outputs
Outputs of similar age
#59,155
of 445,896 outputs
Outputs of similar age from Frontiers in Pharmacology
#26
of 333 outputs
Altmetric has tracked 24,340,143 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 18,285 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 445,896 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 333 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.